The Joint Corp. reports 2024 operating metrics: 9% adjustment growth, LOIs received for majority of corporate clinics

JOINT Corp

2024-FY EPS reported -$0.56 revenue$51,896,605

Performed 14.7 million patient visits in 2024, up from 13.6 million in 2023.
Treated 957,000 new patients, compared to 932,000 in 2023.
System-wide sales grew 9% in 2024, versus 12% in 2023.
Received letters of intent in early January to refranchise majority of corporate clinic portfolio.
Total clinic count expanded to 967 at year-end 2024, from 935 at end of 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.